Hummingbird Bioscience hits drug development milestones, clinical stage status to attract more investors

Hummingbird Bioscience hits drug development milestones, clinical stage status to attract more investors

Antibody visual sourced from Hummingbird's website

Michelle Teo

17 February, 2021

GNTech Venture CapitalHeritas Capital ManagementHummingbird BioscienceMirae Asset CapitalSK Holdings

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.